Table 1. Baseline patient characteristics & prevalence of comorbidities in the study sample.
Baseline characteristics (n = 1852) | |
---|---|
mean (SD) or % | |
Men n (%) | 52% |
Age (years) | 64.1 (13.0) |
BMI (kg/m2) | 27.6 (4.7) |
BMI ≥25 kg/m2 | 70% |
BMI ≥30 kg/m2 | 26% |
SBP | 153.0 (12.4) |
DBP | 88.5 (9.4) |
AHD treatment duration | 8.4 (6.3) |
Good adherence (%) | 62% |
Moderate adherence (%) | 34% |
Bad adherence (%) | 4% |
Grade 1 HT (%) | 60% |
Grade 2 HT (%) | 33% |
Grade 3 HT (%) | 7% |
ISHT (%) | 41% |
IDHT (%) | 3% |
S & D HT (%) | 56% |
Dyslipidaemia | 61% |
Diabetes | 33% |
Prior CV event | 22% |
Peripheral vascular disease | 13% |
Arrhythmias | 13% |
Renal Failure | 8% |
Heart Failure | 5% |
Other comorbidity | 12% |
None | 3% |
≥ 3 Comorbidities (%) | 16% |
Abbreviations: SD: Standard deviation; BMI: Body Mass Index; SBP: Systolic blood pressure; DBP: Diastolic blood pressure; AHD: Antihypertensive drug; HT: Hypertension; ISH: Isolated systolic hypertension; IDHT: Isolated diastolic hypertension; S & D HT: Systolic and diastolic hypertension.